An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 11/28/2024 11:50 PM
Question 20130022
Inquiry Details
References:
Question:
Reportability--Melanoma: Is "early" melanoma reportable? See Discussion.
Discussion:
Because "evolving" melanoma was never reportable, this issue only relates to "early" melanoma.
Answer:
For cases diagnosed 2018 to 2020, early or evolving melanoma is not reportable.
Evolving melanoma (borderline evolving melanoma): Evolving melanoma are tumors of uncertain biologic behavior. Histological changes of borderline evolving melanoma are too subtle for a definitive diagnosis of melanoma in situ. The tumors may be described as "proliferation of atypical melanocytes confined to epidermal and adnexal epithelium," "atypical intraepidermal melanocytic proliferation, "atypical intraepidermal melanocytic hyperplasia"; or "severe melanocytic dysplasia." Not reportable.
Melanoma Solid Tumor Rules, 2018, page 3, https://seer.cancer.gov/tools/solidtumor/Melanoma_STM.pdf
History:
For cases diagnosed 2014-2017
Skin histologies that are not reportable:
Early melanoma
Evolving melanoma
Early/evolving melanoma
Skin histologies that are reportable:
Melanoma, NOS
In situ melanoma
Early in situ melanoma
Evolving in situ melanoma
Early/evolving in situ melanoma
For cases diagnosed 2013-2014
Early melanoma is NOT reportable.
In situ melanoma IS reportable.
Early in situ melanoma IS reportable.
